Addus HomeCare (NASDAQ:ADUS) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Addus HomeCare (NASDAQ:ADUS) from a buy rating to a strong-buy rating in a report released on Saturday morning.

A number of other research analysts have also recently commented on the company. Barclays cut Addus HomeCare from an equal weight rating to an underweight rating and set a $83.00 price target on the stock. in a report on Tuesday, April 23rd. Stephens upped their target price on shares of Addus HomeCare from $120.00 to $128.00 and gave the stock an overweight rating in a research report on Friday, May 31st. Bank of America boosted their price target on shares of Addus HomeCare from $115.00 to $118.00 and gave the stock a buy rating in a research note on Tuesday, May 7th. Macquarie started coverage on Addus HomeCare in a research report on Friday, June 28th. They set an outperform rating and a $136.00 price objective for the company. Finally, Oppenheimer boosted their target price on Addus HomeCare from $118.00 to $130.00 and gave the stock an outperform rating in a research report on Friday, June 7th. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of Moderate Buy and a consensus target price of $116.25.

Addus HomeCare Trading Up 0.4 %

Shares of NASDAQ:ADUS opened at $116.65 on Friday. Addus HomeCare has a 12-month low of $78.35 and a 12-month high of $120.53. The company has a market cap of $1.91 billion, a PE ratio of 28.95, a price-to-earnings-growth ratio of 1.77 and a beta of 1.01. The stock has a 50 day moving average of $110.60 and a 200 day moving average of $100.28. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, May 6th. The company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. The company had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. Addus HomeCare’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.84 EPS. As a group, equities research analysts expect that Addus HomeCare will post 4.36 EPS for the current year.

Insider Activity

In related news, EVP Roberton James Stevenson sold 217 shares of the firm’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,186,500.21. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ADUS. Principal Securities Inc. bought a new position in Addus HomeCare in the fourth quarter worth approximately $26,000. GAMMA Investing LLC bought a new stake in shares of Addus HomeCare in the fourth quarter valued at about $34,000. EntryPoint Capital LLC purchased a new stake in Addus HomeCare in the first quarter worth about $44,000. Assetmark Inc. grew its holdings in Addus HomeCare by 33.3% during the 4th quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock worth $165,000 after acquiring an additional 443 shares in the last quarter. Finally, Mesirow Financial Investment Management Inc. purchased a new position in Addus HomeCare during the 1st quarter valued at about $234,000. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.